These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. MRI-Directed Brachytherapy for Cancer of the Uterine Cervix: A Case Report, Review, and Perspective on the Importance of Widespread Use of This Technological Advance in the United States. Ahmed HZ; Vijayakumar S; Duggar WN; Allbright R Cureus; 2021 Jun; 13(6):e15495. PubMed ID: 34113529 [TBL] [Abstract][Full Text] [Related]
31. Clinical outcomes with MRI-guided image-based brachytherapy in cervical cancer: An institutional experience. Simha V; Rai B; Patel FD; Kapoor R; Sharma SC; Singh OA; Singla V; Dhanireddy B; Ghoshal S Brachytherapy; 2018; 17(2):345-351. PubMed ID: 29102740 [TBL] [Abstract][Full Text] [Related]
32. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy. Chen CC; Wang L; Lin JC; Jan JS J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974 [TBL] [Abstract][Full Text] [Related]
33. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904 [TBL] [Abstract][Full Text] [Related]
35. Reporting and validation of gynaecological Groupe Euopeen de Curietherapie European Society for Therapeutic Radiology and Oncology (ESTRO) brachytherapy recommendations for MR image-based dose volume parameters and clinical outcome with high dose-rate brachytherapy in cervical cancers: a single-institution initial experience. Mahantshetty U; Swamidas J; Khanna N; Engineer R; Merchant NH; Deshpande DD; Shrivastava S Int J Gynecol Cancer; 2011 Aug; 21(6):1110-6. PubMed ID: 21633296 [TBL] [Abstract][Full Text] [Related]
36. Distant metastasis in patients with cervical cancer after primary radiotherapy with or without chemotherapy and image guided adaptive brachytherapy. Schmid MP; Franckena M; Kirchheiner K; Sturdza A; Georg P; Dörr W; Pötter R Gynecol Oncol; 2014 May; 133(2):256-62. PubMed ID: 24517875 [TBL] [Abstract][Full Text] [Related]
37. Safety and efficacy of semiextended field intensity-modulated radiation therapy and concurrent cisplatin in locally advanced cervical cancer patients: An observational study of 10-year experience. Lee J; Lin JB; Sun FJ; Chen YJ; Chang CL; Jan YT; Wu MH Medicine (Baltimore); 2017 Mar; 96(10):e6158. PubMed ID: 28272204 [TBL] [Abstract][Full Text] [Related]
39. Impact of treatment time and dose escalation on local control in locally advanced cervical cancer treated by chemoradiation and image-guided pulsed-dose rate adaptive brachytherapy. Mazeron R; Castelnau-Marchand P; Dumas I; del Campo ER; Kom LK; Martinetti F; Farha G; Tailleur A; Morice P; Chargari C; Lefkopoulos D; Haie-Meder C Radiother Oncol; 2015 Feb; 114(2):257-63. PubMed ID: 25497872 [TBL] [Abstract][Full Text] [Related]
40. Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: Phase II study of the Radiation Therapy Oncology Group 92-10. Grigsby PW; Lu JD; Mutch DG; Kim RY; Eifel PJ Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):817-22. PubMed ID: 9652843 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]